|
RVPH Reviva Pharmaceuticals Holdings Inc 1742927 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,195,987.00 |
| Balance Sheet |
|
Current Assets
|
$23,559,636.00 |
|
Assets
|
$23,559,636.00 |
|
Current Liabilities
|
$6,119,155.00 |
|
Liabilities
|
$6,119,155.00 |
|
Equity
|
$17,440,481.00 |
|
Shares Out
|
12810377.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,801,296.00 |
| Market Analysis |
Market Cap
|
$5,636,565.88 |
|
Price
|
$0.44 |
|
BVPS
|
1.36 |
|
PB
|
0.32 |
|
EPS
|
-0.46 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-5.48 |
|
|
2026-05-13 |
-0.46 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.12 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RVPH documents filed with the SEC.
RVPH Filings
Clear
